HOLLY MCCORMICK: Open Payments
NPI 1346291994 · CADIZ, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 38 payments from 12 companies in 2025. Trend: 2023 $774 · 2024 $1,051 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $238 |
| Amgen Inc. | 10 | $199 |
| ABBVIE INC. | 10 | $140 |
| AstraZeneca Pharmaceuticals LP | 2 | $71 |
| Novo Nordisk Inc | 2 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Auvelity, OTEZLA, VRAYLAR, AIRSUPRA, Wegovy, FANAPT, REPATHA, UBRELVY.
Industry payments across KY — which companies pay providers there.
